Literature DB >> 18203295

Expression of SOCS-1 in the liver tissues of chronic hepatitis B and its clinical significance.

Zhi-Xin Zhao1, Qing-Xian Cai, Xiao-Mou Peng, Yu-Tian Chong, Zhi-Liang Gao.   

Abstract

AIM: To study the expression of suppressor of cytokine signaling-1 (SOCS-1) in the liver tissues of chronic hepatitis B (CHB) and the clinical significance of this expression.
METHODS: The expression of SOCS-1 in liver tissues of 45 cases of CHB was investigated by immunohistochemical staining, and its correlations with inflammation grades and fibrosis stage were analyzed by SPSS statistics software.
RESULTS: The result showed SOCS-1 expressing could be observed in the liver tissue of CHB. The expression of SOCS-1 was mainly distributed near the portal area in the liver tissue of mild inflammation CHB group, and was diffusely distributed in the liver tissue of moderate and severe inflammation groups. SOCS-1 positive stains mainly appear in the hepatocytes, only a few of liver interstitial cells were involved. Inside the hepatocyte, SOCS-1 positive stains are mainly distributed in the plasma. Some of the staining was observed on the membrane. The inclusion bodies in the plasma of hepatocytes were observed occasionally. There were both obvious correlations between the expression of SOCS-1 and the inflammatory grade, and that between the expression of SOCS-1 and the fibrosis stage.
CONCLUSION: The distribution of SOCS-1 in the liver tissue of CHB is variable. This expression was correlated with the inflammation grade and fibrosis stage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203295      PMCID: PMC2681154          DOI: 10.3748/wjg.14.607

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice.

Authors:  T Naka; T Matsumoto; M Narazaki; M Fujimoto; Y Morita; Y Ohsawa; H Saito; T Nagasawa; Y Uchiyama; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma.

Authors:  Roumen Balabanov; Krystal Strand; April Kemper; Ji Yeon Lee; Brian Popko
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

4.  Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy.

Authors:  K Imanaka; S Tamura; K Fukui; N Ito; S Kiso; Y Imai; T Naka; T Kishimoto; S Kawata; Y Shinomura
Journal:  J Viral Hepat       Date:  2005-03       Impact factor: 3.728

5.  Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues.

Authors:  M Shimizu; Y Saitoh; H Itoh
Journal:  Hum Pathol       Date:  1990-06       Impact factor: 3.466

6.  Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency.

Authors:  Ye Chen; Mark M W Chong; Rima Darwiche; Helen E Thomas; Thomas W H Kay
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 7.  [Progress of study on suppressor of cytokine signaling-1 - review].

Authors:  Hai-Ping Yang; Min Dai; Dong-Hua Zhang
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2007-04

8.  Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases.

Authors:  Minoru Fujimoto; Hiroko Tsutsui; Ouyang Xinshou; Masanori Tokumoto; Dai Watanabe; Yoshihito Shima; Tomohiro Yoshimoto; Hideki Hirakata; Ichiro Kawase; Kenji Nakanishi; Tadamitsu Kishimoto; Tetsuji Naka
Journal:  Int Immunol       Date:  2004-02       Impact factor: 4.823

9.  Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.

Authors:  Toshiaki Komazaki; Hisaki Nagai; Mitsuru Emi; Yoshie Terada; Aya Yabe; Enjing Jin; Ooiti Kawanami; Noboru Konishi; Yukichi Moriyama; Tetsuji Naka; Tadamitsu Kishimoto
Journal:  Jpn J Clin Oncol       Date:  2004-04       Impact factor: 3.019

10.  IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3.

Authors:  Cristina Albanesi; Heather R Fairchild; Stefania Madonna; Claudia Scarponi; Ornella De Pità; Donald Y M Leung; Michael D Howell
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

View more
  5 in total

1.  Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis.

Authors:  Hui Zhang; Jianchun Xian; Yang Li; Li Xiao; Lu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-30       Impact factor: 2.650

2.  Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment.

Authors:  Jian-Jun Zhang; Yu-Chen Fan; Ze-Hua Zhao; Yang Yang; Cheng-Yun Dou; Shuai Gao; Kai Wang
Journal:  Cell Mol Immunol       Date:  2014-04-14       Impact factor: 11.530

3.  Reduced SOCS1 Expression in Lung Fibroblasts from Patients with IPF Is Not Mediated by Promoter Methylation or Mir155.

Authors:  Cecilia M Prêle; Thomas Iosifidis; Robin J McAnulty; David R Pearce; Bahareh Badrian; Tylah Miles; Sarra E Jamieson; Matthias Ernst; Philip J Thompson; Geoffrey J Laurent; Darryl A Knight; Steven E Mutsaers
Journal:  Biomedicines       Date:  2021-04-30

4.  Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.

Authors:  Rong Qi Wang; Yue Min Nan; Wen Juan Wu; Ling Bo Kong; Fang Han; Su Xian Zhao; Li Kong; Jun Yu
Journal:  Lipids Health Dis       Date:  2011-02-12       Impact factor: 3.876

5.  SOCS1 regulates hepatic regenerative response and provides prognostic makers for acute obstructive cholangitis.

Authors:  Jianhua Yu; Weiguang Zhang; Hongwei Qian; Haijun Tang; Weiguo Lin; Baochun Lu
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.